NasdaqCM - Delayed Quote • USD
FONAR Corporation (FONR)
At close: 4:00 PM EDT
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
102,422.10
98,645.10
97,592.15
89,929.77
85,690.46
Cost of Revenue
55,648.16
52,897.16
50,578.20
46,456.13
43,296.83
Gross Profit
46,773.94
45,747.94
47,013.94
43,473.64
42,393.64
Operating Expense
28,671.68
30,958.68
25,006.76
26,376.02
28,742.72
Operating Income
18,102.26
14,789.26
22,007.18
17,097.62
13,650.92
Net Non Operating Interest Income Expense
-81.13
-50.13
-346.55
-248.67
-74.32
Other Income Expense
2,420.46
1,019.46
1,108.25
816.38
572.92
Pretax Income
20,441.59
15,758.59
22,768.88
17,665.33
14,149.51
Tax Provision
3,797.07
3,632.07
5,534.49
3,991.52
2,444.78
Net Income Common Stockholders
12,156.97
8,801.97
11,690.80
9,592.13
7,735.65
Diluted NI Available to Com Stockholders
12,156.97
8,801.97
11,690.80
9,592.13
7,735.65
Basic EPS
1.87
1.35
1.78
1.47
1.20
Diluted EPS
1.84
1.32
1.75
1.45
1.18
Basic Average Shares
6,496.38
6,539.38
6,554.21
6,505.28
6,443.71
Diluted Average Shares
6,623.88
6,666.88
6,681.71
6,632.79
6,571.22
Total Operating Income as Reported
18,102.26
14,789.26
22,007.18
17,097.62
13,650.92
Total Expenses
84,319.84
83,855.84
75,584.96
72,832.15
72,039.55
Net Income from Continuing & Discontinued Operation
12,961.78
9,375.78
12,440.91
10,207.59
8,240.21
Normalized Income
11,456.90
8,434.70
12,253.81
9,966.15
7,824.82
Interest Income
--
--
--
--
502.15
Interest Expense
81.13
50.13
346.55
248.67
74.32
Net Interest Income
-81.13
-50.13
-346.55
-248.67
-74.32
EBIT
20,522.72
15,808.72
23,115.43
17,914.00
14,223.83
EBITDA
29,432.67
24,613.67
31,650.79
23,453.74
19,138.04
Reconciled Cost of Revenue
55,648.16
52,897.16
50,578.20
46,456.13
43,296.83
Reconciled Depreciation
8,909.95
8,804.95
8,535.37
5,539.74
4,914.21
Net Income from Continuing Operation Net Minority Interest
12,961.78
9,375.78
12,440.91
10,207.59
8,240.21
Total Unusual Items Excluding Goodwill
1,848.18
1,222.18
247.16
311.93
502.15
Total Unusual Items
1,848.18
1,222.18
247.16
311.93
502.15
Normalized EBITDA
27,584.50
23,391.50
31,403.64
23,141.81
18,635.90
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
343.30
281.10
60.06
70.50
86.76
6/30/2020 - 10/29/1981
Yahoo Finance Plus Essential access required. Unlock Access
Related Tickers
PMD Psychemedics Corporation
2.5700
+0.78%
IDXG Interpace Biosciences, Inc.
1.4500
-1.36%
STRR Star Equity Holdings, Inc.
0.8630
+0.47%
BNR Burning Rock Biotech Limited
0.7200
-10.00%
PRE Prenetics Global Limited
2.9000
-9.09%
XGN Exagen Inc.
1.3700
+0.74%
OLK Olink Holding AB (publ)
21.87
-1.80%
ENZ Enzo Biochem, Inc.
1.0900
-3.54%
RVTY Revvity, Inc.
100.86
+1.49%
AWH Aspira Women's Health Inc.
3.4900
0.00%